ANN – cichy złodziej życia Punkty widzenia alergologa i psychiatry

Abstract

Allergic rhinitis (AR) is one of the most common chronic respiratory diseases, affecting up to 20–30% of the population in developed countries. The disease significantly reduces patients’ quality of life, impacts sleep, concentration, work and learning performance, and is closely associated with bronchial asthma. The contemporary approach to AR is based on the one airway concept, according to which the inflammatory process involves both the upper and lower respiratory tracts.

Allergic rhinitis (AR) affects approximately 9 million individuals in Poland. Metaanalyses indicate that patients with AR have a significantly higher risk of anxiety and depressive symptoms compared to the general population. AR is associated with sleep disturbances, depressed mood, chronic fatigue, suicidal ideation, and problem with concentration. Recently, the issue of sexual dysfunction in AR patients has also been raised. Patients with AR and comorbid psychiatric disorders demonstrate poorer adherence, and distinguishing between primary depression and depression secondary to AR is a diagnostic challenge. An interdisciplinary approach is recommended; however, when psychiatric disorders are secondary to AR, the treatment of AR should be prioritized. Psychiatric disorders in AR patients are well-documented both clinically and epidemiologically. In clinical practice, clinicians should inquire about sleep and sexual function – domains often neglected in standard history-taking. Effective AR treatment reduces the risk of psychiatric disorders and improves patients’ quality of life.